Bandingkan Harga & Kinerja Xolare RCR Energy Tbk. (SOLA) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Xolare RCR Energy Tbk. dan Tempo Scan Pacific Tbk.: Xolare RCR Energy Tbk. diperdagangkan di Rp107 (kapitalisasi pasar 351,75 M, volume 24 jam 5,75 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 33,2× kapitalisasi pasar Xolare RCR Energy Tbk., dan Xolare RCR Energy Tbk. lebih aktif diperdagangkan (5,75 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| SOLA | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 351,75 M | 11,68 T |
Volume | 5,75 jt | 429,7 rb |
Lot | 57,52 rb | 4,3 rb |
Perputaran | 611,38 jt | 1,11 M |
Harga Rata-rata | 106,29 | 2.591,65 |
Nilai Transaksi | 611,38 jt | 1,11 M |
Harga Ekuilibrium Indikatif | 107 | 2.580 |
Volume Ekuilibrium Indikatif | 1,98 rb | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Xolare RCR Energy Tbk.
PT Xolare RCR Energy (Formerly: PT RCR Energy Indonesia) (the "Company") was established based on Notarial Deed No. 213 dated December 18, 2014 drawn up before Notary Humberg Lie, S.H., S.E., M.Kn., in Jakarta. The ultimate beneficial owner of the Company is PT Energi Hijau Investama. The Company started its commercial activities in 2015.
Selengkapnya di halaman SOLA →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
